Efek Pandemi Covid-19 terhadap Pemeriksaan Tes Cepat Molekuler Kasus Tuberculosis Paru di RSUD Tgk Chik Ditiro Sigli
Abstract
Tujuan penelitian untuk mengetahui adanya perbedaan pemeriksaan TCM kasus TB Paru, diagnosis TB Paru dan kasus TB Paru resisten rifamfisin sebelum dan selama pandemi COVID-19 di RSUD Tgk Chik Ditiro Sigli. Penelitian dilakukan di RSUD Tgk Chik Ditiro Sigli dari Januari 2023 sampai Juli 2024. Desain penelitian analitik komparatif menggunakan data retrospektif untuk menganalisis efek pandemi Covid-19 terhadap angka pemeriksaan Tuberculosis Paru di RSUD Tgk Chik Ditiro Sigli. Sumber data dalam penelitian adalah data sekunder dari aporan pemeriksaan TCM mulai Trimester II 2018 sampai Trimester I 2022. Analisis data dilakukan melalui analisis univariat dengan memaparkan distribusi frekuensi dan analisis bivariat menggunakan paired t-test. Hasil menunjukkan pemeriksaan TCM sebelum pandemi Covid-19 paling banyak dilakukan pada trimester IV 2019 sebanyak 567 suspek (18,7%), sedangkan selama Covid -19 paling banyak pada trimester I 2021, 446 kasus (22%). Kasus terdiagnosis TB Paru sebelum Covid -19 paling banyak pada trimester II 2019 yaitu 97 kasus (29,04%) dan setelah Covid -19 paling banyak trimester II 2020 yaitu 81 kasus (23,68%). Kasus resisten rifampisin sebelum Covid -19 paling banyak ditemukan pada trimester III 2018 yaitu 12 kasus (14,3%) dan setelah Covid -19 terbanyak pada trimester I 2021 dengan 8 kasus (11%). Kesimpulan penelitian ada perbedaan bermakna pemeriksaan TCM kasus TB Paru sebelum dan selama pandemi Covid -19, ada perbedaan bermakna suspek yang positif TB Paru sebelum dan selama pandemi Covid -19 dan ada perbedaan bermakna kasus resisten rifampisin sebelum dan selama pandemi Covid -19 di RSUD Tgk Chik Ditiro Sigli.
Downloads
Copyright (c) 2024 Muhammad Rifqi Maulana, Yopie Afriandi Habibie, Nurrahmah Yusuf Irfan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
.png)
